MCID: GST050
MIFTS: 66

Gastrointestinal System Disease

Categories: Gastrointestinal diseases

Aliases & Classifications for Gastrointestinal System Disease

MalaCards integrated aliases for Gastrointestinal System Disease:

Name: Gastrointestinal System Disease 12 14
Gastrointestinal Diseases 51 69
Digestive System Disorders 69
Alimentary System Disease 12
Digestive System Disorder 12
Gastrointestinal Disorder 12
Digestive System Diseases 41
Gastrointestinal Disease 12
Gastroenteropathy 12
Git Disease 12

Classifications:



External Ids:

Disease Ontology 12 DOID:77
ICD9CM 34 520-579.99
MeSH 41 D004066

Summaries for Gastrointestinal System Disease

Disease Ontology : 12 A disease of anatomical entity that is located in the gastrointestinal tract.

MalaCards based summary : Gastrointestinal System Disease, also known as gastrointestinal diseases, is related to celiac disease 1 and esophageal disease, and has symptoms including peeling tongue, catarrh and blood in stool. An important gene associated with Gastrointestinal System Disease is TRPV1 (Transient Receptor Potential Cation Channel Subfamily V Member 1), and among its related pathways/superpathways are Peptide ligand-binding receptors and IL-17 Family Signaling Pathways. The drugs Ethanol and Heparin have been mentioned in the context of this disorder. Affiliated tissues include the gastrointestinal tract, liver and colon, and related phenotypes are digestive/alimentary and homeostasis/metabolism

Wikipedia : 72 Gastrointestinal diseases refer to diseases involving the gastrointestinal tract, namely the esophagus,... more...

Related Diseases for Gastrointestinal System Disease

Diseases related to Gastrointestinal System Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 192)
# Related Disease Score Top Affiliating Genes
1 celiac disease 1 32.4 ALB CCK GHRL PYY TNF
2 esophageal disease 32.2 ATP12A ATP4A GAST TRPV1
3 mouth disease 32.2 IL1B TLR9 TNF TRPV1
4 gallbladder disease 32.2 CCK CCKAR MLN
5 diarrhea 32.2 ALB CCK GAST TNF
6 peritonitis 32.1 ALB IL1B TNF
7 polyposis, skin pigmentation, alopecia, and fingernail changes 32.0 ALB ATP12A ATP4A
8 intestinal disease 31.6 ALB AREG GCG GHRL HTR4 IL1B
9 stomach disease 31.5 AREG ATP12A ATP4A CCK GAST GHRL
10 gastroenteritis 31.0 ALB CCL11 IL1B TNF
11 appendicitis 30.9 ALB IL1B TNF
12 irritable bowel syndrome 30.8 CCK HTR4 MLN TLR9 TNF TRPV1
13 gastritis 30.8 AREG GAST GHRL IL1B S100A8
14 duodenitis 30.8 ATP12A ATP4A GAST
15 dyspepsia 30.7 CCK CCKAR GHRL TRPV1
16 eating disorder 30.6 CCK GHRL PYY
17 constipation 30.6 CCK GAST HTR4 MLN PYY
18 helicobacter pylori infection 30.5 GAST IL1B S100A8 TNF
19 colitis 30.3 IL1B MADCAM1 TLR9 TNF
20 body mass index quantitative trait locus 11 30.3 CCK CCKAR GCG GHRL PYY TNF
21 gastritis, familial giant hypertrophic 10.9
22 eosinophilic enteropathy 10.9
23 bile reflux 10.8 ATP12A ATP4A CCK
24 opioid abuse 10.8 CCK CCKAR TRPV1
25 gastrointestinal neuroendocrine benign tumor 10.8 ATP12A ATP4A GAST
26 gastric neuroendocrine neoplasm 10.8 ATP12A ATP4A GAST
27 granulomatous gastritis 10.8 ATP12A ATP4A GAST
28 eosinophilic gastritis 10.8 ATP12A ATP4A CCL11
29 capillary disease 10.8 ALB ATP12A ATP4A
30 lymphocytic colitis 10.8 ATP12A ATP4A PYY
31 fungal esophagitis 10.8 ATP12A ATP4A
32 peptic esophagitis 10.8 ATP12A ATP4A IL1B
33 nasal cavity disease 10.8 CCL11 TLR9 TRPV1
34 duodenal gastrinoma 10.8 CCK GAST SCT
35 clostridium difficile colitis 10.8 ATP12A ATP4A IL1B
36 polyposis, gastric 10.8 IL1B TNF
37 duodenal disease 10.8 ATP12A ATP4A CCK SCT
38 esophageal varix 10.8 ALB ATP12A ATP4A
39 pneumatosis cystoides intestinalis 10.8 ATP12A ATP4A PYY
40 exocrine pancreatic insufficiency 10.8 CCK CCKAR SCT
41 postcholecystectomy syndrome 10.8 CCK GAST MLN
42 aspiration pneumonia 10.8 ALB ATP12A ATP4A TRPV1
43 nose disease 10.8 CCL11 TLR9 TNF TRPV1
44 burning mouth syndrome 10.8 IL1B TNF TRPV1
45 dental pulp disease 10.8 IL1B TNF TRPV1
46 upper respiratory tract disease 10.8 CCL11 TLR9 TNF TRPV1
47 esophagitis, eosinophilic, 1 10.8 ATP12A ATP4A CCL11
48 bladder calculus 10.8 ATP12A ATP4A
49 burns 10.8 ALB IL1B TNF
50 central nervous system vasculitis 10.8 IL1B TLR9 TNF

Graphical network of the top 20 diseases related to Gastrointestinal System Disease:



Diseases related to Gastrointestinal System Disease

Symptoms & Phenotypes for Gastrointestinal System Disease

UMLS symptoms related to Gastrointestinal System Disease:


peeling tongue, catarrh, blood in stool, epigastric discomfort, abdominal bloating, anal discomfort, abdominal distress/pain as reason for upper g.i. examination, abdominal distress/pain as reason for lower g.i. examination, vomiting alone, gastrointestinal pain, digestive system symptom, sore lip, gastrointestinal symptoms, swallowing problems, gastric irritation, stomach cramps (finding), change in bowel habits, vomiting in newborn, infantile colic, anal pain, abdominal distention, gaseous, salivary gland pain, abdominal fullness, upset stomach, epigastric food-related pain, right upper quadrant pain, epigastric pain not food-related, abdominal distress, hyperemesis, dry throat, rectal tenesmus, retching, lower abdominal pain, upper abdominal pain, abdominal discomfort, decrease in appetite, odynophagia, other symptoms involving digestive system, symptoms involving digestive system, liver tender, vomiting, signs and symptoms, digestive, rectal pain, nausea, heartburn, halitosis, glossalgia, flatulence, eructation, and gas pain, flatulence, eructation, dyspepsia, diarrhea, constipation, abdominal pain, abdominal cramps, abdomen, acute, gastrointestinal gas, signs and symptoms of ill-defined conditions, pathological conditions, signs and symptoms, oral manifestations, nausea and vomiting, icterus

MGI Mouse Phenotypes related to Gastrointestinal System Disease:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.61 GHRL TLR9 TNF ALB AREG ATP12A
2 homeostasis/metabolism MP:0005376 9.47 GHRL HTR4 IL1B PYY TLR9 TNF

Drugs & Therapeutics for Gastrointestinal System Disease

Drugs for Gastrointestinal System Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1396)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ethanol Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 64-17-5 702
2
Heparin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 9005-49-6 46507594 772
3
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-61-6, 62-31-7 681
4
Clonidine Approved Phase 4,Phase 3,Phase 2,Phase 1 4205-90-7 2803
5
Nitric Oxide Approved Phase 4,Phase 3,Phase 1,Phase 2 10102-43-9 145068
6
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-02-2 5743
7
Mannitol Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 69-65-8 6251 453
8
Gabapentin Approved, Investigational Phase 4,Phase 3,Phase 2 60142-96-3 3446
9
Rosiglitazone Approved, Investigational Phase 4,Phase 2,Phase 1 122320-73-4 77999
10
Ezetimibe Approved Phase 4,Phase 2 163222-33-1 150311
11
Pravastatin Approved Phase 4 81093-37-0 54687
12
Pioglitazone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 111025-46-8 4829
13
Simvastatin Approved Phase 4,Phase 2,Phase 3,Phase 1 79902-63-9 54454
14
Zinc Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 7440-66-6 32051 23994
15
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 104987-11-3 445643 439492
16
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-78-2 2244
17
Colchicine Approved Phase 4,Phase 3,Phase 1 64-86-8 2833 6167
18
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
19
Methotrexate Approved Phase 4,Phase 2,Phase 3,Phase 1 1959-05-2, 59-05-2 126941
20
Rifampin Approved Phase 4,Phase 1 13292-46-1 5381226 5458213
21
Irinotecan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 97682-44-5, 100286-90-6 60838
22
Loperamide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 53179-11-6 3955
23
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 51-43-4 5816
24
Midazolam Approved, Illicit Phase 4,Phase 2,Phase 3,Phase 1 59467-70-8 4192
25
Erythromycin Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 114-07-8 12560
26
Ursodeoxycholic acid Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 128-13-2 31401
27
Iron Approved Phase 4,Phase 3,Phase 2,Phase 1 7439-89-6 23925
28
Indomethacin Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 53-86-1 3715
29
Mycophenolic acid Approved Phase 4,Phase 3,Phase 1,Phase 2 24280-93-1 446541
30
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 128794-94-5 5281078
31
Pantoprazole Approved Phase 4,Phase 3,Phase 2,Phase 1 102625-70-7 4679
32
Diclofenac Approved, Vet_approved Phase 4,Phase 2,Phase 1 15307-86-5 3033
33
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 73590-58-6 4594
34
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 85721-33-1 2764
35
Morphine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 57-27-2 5288826
36
Acetaminophen Approved Phase 4,Phase 3,Phase 2,Phase 1 103-90-2 1983
37
Lamivudine Approved, Investigational Phase 4,Phase 1,Phase 2 134678-17-4 60825
38
Metformin Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 657-24-9 4091 14219
39
Prazosin Approved Phase 4 19216-56-9 4893
40
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 9004-61-9 53477741 24759
41
Perindopril Approved Phase 4,Phase 2 107133-36-8, 82834-16-0 107807
42
Losartan Approved Phase 4,Phase 3,Phase 2 114798-26-4 3961
43
Spironolactone Approved Phase 4,Phase 2,Phase 3 1952-01-7, 52-01-7 5833
44
Telmisartan Approved, Investigational Phase 4 144701-48-4 65999
45
Amlodipine Approved Phase 4,Phase 1,Phase 2 88150-42-9 2162
46
Carvedilol Approved, Investigational Phase 4,Phase 3 72956-09-3 2585
47
Isosorbide Dinitrate Approved, Investigational Phase 4,Phase 1 87-33-2 6883
48
Clopidogrel Approved Phase 4,Phase 3,Phase 2 120202-66-6, 113665-84-2 60606
49
Diltiazem Approved, Investigational Phase 4,Phase 3,Phase 1 42399-41-7 39186
50
Warfarin Approved Phase 4,Phase 3,Phase 2,Phase 1 81-81-2 54678486 6691

Interventional clinical trials:

(show top 50) (show all 10000)

# Name Status NCT ID Phase Drugs
1 The Treatment of Periodontal Diseases Unknown status NCT01318928 Phase 4 Metronidazol
2 Prophylactic Pancreatic Duct Stent Placement After ESP of Major Papillary Tumors; Prospective, Randomized Study Unknown status NCT01737463 Phase 4
3 THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS Unknown status NCT02241876 Phase 4 N-acetylcysteine
4 Prospective Random Comparing Study on EUS-guided Pseudocyst Drainage by Naso-pancreatic Tube and Stents Unknown status NCT01585662 Phase 4
5 Mast Cells in Acid-induced Intestinal Permeability Unknown status NCT02664051 Phase 4 Nalcrom;placebo
6 The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Taking Aspirin Unknown status NCT01549418 Phase 4 Aspirin (ASA);Placebo
7 Diverticulitis: Antibiotics or Close Observation? Unknown status NCT01111253 Phase 4 Amoxicillin-clavulanate
8 Double- Versus Single-balloon Enteroscopy for Obscure Small-bowel Bleeding Unknown status NCT01176864 Phase 4
9 Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease Unknown status NCT02213224 Phase 4 Perindopril;Telmisartan;Amlodipine
10 The Effect Of Dual Treatment With L-Carnitine And Magnesium On Fatty Liver Unknown status NCT01956825 Phase 4
11 The Orange-III Trial: Optimised Recovery With Movicol® Preoperatively Within an Enhanced Recovery Programme Unknown status NCT01429779 Phase 4 Movicol
12 Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease Unknown status NCT00941642 Phase 4 Lovaza;placebo control
13 Effect of an Artificial Pancreas in Patients Undergoing Pancreatic Resection Unknown status NCT00661648 Phase 4
14 A Study of Thymoglobulin and Tacrolimus in Liver Transplant Unknown status NCT00564538 Phase 4 anti-thymocyte globulin (rabbit);tacrolimus
15 Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography Unknown status NCT00155376 Phase 4 morphine and glucagon
16 Analgesic Efficacy of Intravenous Hyoscine-N-Butylbromide (HNB) in Abdominal Colic Associated With Acute Gastroenteritis Unknown status NCT02508142 Phase 4 Hyoscine-N-Butylbromide
17 Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure Unknown status NCT01968395 Phase 4 Caspofungin 70 mg
18 Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab Unknown status NCT02453776 Phase 4 PRECISION dosing Infliximab
19 Dexmedetomidine Hydrochloride in the Prevention of Organ Failure Following Severe Acute Pancreatitis Unknown status NCT02691598 Phase 4 Infusion
20 Complex Imaging Assessment of Steatosis Unknown status NCT02669641 Phase 4
21 Epidural Analgesia for Pancreatitis (Epipan Study) Unknown status NCT02126332 Phase 4
22 Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip Unknown status NCT02537353 Phase 4 Hemospray;Adrenaline
23 TO Compare the Triple Drug Therapy and Dual Therapy . Unknown status NCT02075242 Phase 4 Mycophenolate Mofetil;Tacrolimus
24 Multi-center Clinical Study of Early Antibios of Severe Acute Pancreatitis Unknown status NCT01992198 Phase 4 cefoperazone + metronidazole;Somatostatin;Meropenem
25 Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic Steatohepatitis Unknown status NCT01950884 Phase 4 Ezetimibe
26 Outcome Study of Double Bare Stent for Malignant Gastric Outlet Obstruction Unknown status NCT02156505 Phase 4
27 Comparative Study About the Impact of Two Oil Emulsions Administered Intravenously on Severe Acute Pancreatitis Unknown status NCT01376817 Phase 4 Fat emulsion with MCT, LCT, olive oil and omega 3 fatty acids;Fat emulsion with MCT and LCT
28 A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol Unknown status NCT01298284 Phase 4 propranolol
29 A Double Blind Study Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy Unknown status NCT01275937 Phase 4 Esomeprazole;esomeprazole
30 The Impact of Rockall Risk Scoring System on Management of Upper Gastrointestinal System Bleeding Unknown status NCT01269814 Phase 4
31 Single-Operator Versus Dual-Operator Double-balloon Endoscopy in Patients With Small-Bowel Disorders Unknown status NCT01184690 Phase 4
32 Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding Unknown status NCT00567216 Phase 4 Nadolol
33 Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal Bleeding Unknown status NCT00861640 Phase 4 Intravenous Omeprazole;Oral Rabeprazole
34 Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients Unknown status NCT02605213 Phase 4 Vancomycin;Placebo
35 Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia Unknown status NCT02493231 Phase 4 Nefopam;Ketamine;Saline
36 Withholding Feeds During Red Blood Cell Transfusion and TRAGI Unknown status NCT02132819 Phase 4
37 Rifaximin Predicts the Complications of Decompensated Cirrhosis Unknown status NCT02074280 Phase 4 rifaximin
38 Extended Antibiotic Therapy in Postoperative of Laparoscopic Cholecystectomy in Acute Cholecystitis Unknown status NCT02057679 Phase 4 Amoxicillin clavulanic;Placebo
39 Magnesium in Liver Cirrhosis Unknown status NCT01894867 Phase 4
40 Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial Unknown status NCT01799486 Phase 4 Telbivudine;Enecavir;Adefovir
41 Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium Unknown status NCT01783314 Phase 4
42 Telbivudine Renoprotective Effect in Patients With HBV-related Liver Cirrhosis Unknown status NCT01693679 Phase 4 Telbivudine, Lamivudine, Adefovir ,Enecavir
43 Efficacy and Safety of Floseal for the Haemostasis During Laparoscopic Cholecystectomy in Acute Cholecystitis (GLA) Unknown status NCT01126281 Phase 4
44 RCT of Carvedilol Versus Variceal Band Ligation in the Primary Prophylaxis of Oesophageal Variceal Haemorrhage Unknown status NCT01070641 Phase 4 Carvedilol
45 Effect of Mosapride on Postoperative Ileus in Patients Undergoing Colorectal Surgery Unknown status NCT02056405 Phase 4 Mosapride;Placebo
46 Confocal Endomicroscopy During Endoscopy Unknown status NCT00988273 Phase 4
47 Echocardiographic Assessment of Intrapulmonary Vasodilatation: Agitated Saline Versus Polygeline Unknown status NCT00343122 Phase 4
48 Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis Unknown status NCT00332904 Phase 4 propranolol;spironolactone
49 Oral Hygiene Regimen in Patients on HCT Unknown status NCT02662374 Phase 4 .02% Chlorohexidine Gluconate;3% Sodium Bicarbonate;Nystatin 10000U/ml;Supersaturated Calcium Phosphate
50 "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial" Unknown status NCT02452151 Phase 4 Infliximab-Biosimilar;Infliximab-Innovator

Search NIH Clinical Center for Gastrointestinal System Disease

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: digestive system diseases

Genetic Tests for Gastrointestinal System Disease

Anatomical Context for Gastrointestinal System Disease

The Foundational Model of Anatomy Ontology organs/tissues related to Gastrointestinal System Disease:

18
The Gastrointestinal Tract

MalaCards organs/tissues related to Gastrointestinal System Disease:

38
Liver, Colon, Testes, Bone, T Cells, Lymph Node, Lung

Publications for Gastrointestinal System Disease

Articles related to Gastrointestinal System Disease:

(show top 50) (show all 93)
# Title Authors Year
1
Frequency, Diagnosis, Treatment, and Outcome of Gastrointestinal Disease in Granulomatosis with Polyangiitis and Microscopic Polyangiitis. ( 29419474 )
2018
2
Gastrointestinal diseases and their oro-dental manifestations: Part 2: Ulcerative colitis. ( 28084352 )
2017
3
Gastrointestinal diseases and their oro-dental manifestations: Part 4: Peutz-Jeghers syndrome. ( 28184053 )
2017
4
Food IgG4 antibodies are elevated not only in children with wheat allergy but also in children with gastrointestinal diseases. ( 27004959 )
2016
5
Familial Adenomatous Polyposis Manifesting as Lactococcus Endocarditis: A Case Report and Review of the Association of Lactococcus with Underlying Gastrointestinal Disease. ( 27818810 )
2016
6
Elevated levels of faecal calprotectin in primary SjAPgren's syndrome is common and associated with concomitant organic gastrointestinal disease. ( 26759247 )
2016
7
Elevated DMBT1 levels in neonatal gastrointestinal diseases. ( 26542257 )
2016
8
From past sailors' eras to the present day: scurvy as a surprising manifestation of an uncommon gastrointestinal disease. ( 26376699 )
2015
9
Prevalence of Lactose Malabsorption and Lactose Intolerance in Pediatric Patients with Selected Gastrointestinal Diseases. ( 26768639 )
2015
10
Protective role of hemeoxygenase-1 in gastrointestinal diseases. ( 25428780 )
2015
11
[The development of functional gastrointestinal diseases: Genetic aspects]. ( 28635880 )
2015
12
A meta-analysis: The association between interleukin-17 pathway gene polymorphism and gastrointestinal diseases. ( 26164762 )
2015
13
Differential expression and processing of matrix metalloproteinase 19 marks progression of gastrointestinal diseases. ( 25056434 )
2014
14
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response. ( 23791986 )
2013
15
Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy. ( 23180439 )
2013
16
Multiple-dose therapy with bovine colostrum confers significant protection against diarrhea in a mouse model of human rotavirus-induced gastrointestinal disease. ( 23200479 )
2013
17
A possible role of IL-1RN gene polymorphism in the outcome of gastrointestinal diseases associated with H. pylori infection. ( 23637547 )
2013
18
Progressive multifocal leukoencephalopathy with gastrointestinal disease in a pediatric kidney transplant recipient. ( 23902604 )
2013
19
The role of endoscopy and biopsy in the management of severe gastrointestinal disease in cystic fibrosis patients. ( 23825099 )
2013
20
The role of peptide YY in gastrointestinal diseases and disorders (review). ( 23292145 )
2013
21
Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome. ( 23061432 )
2012
22
Laparoscopic bladder-preserving surgery for enterovesical fistula complicated with benign gastrointestinal disease. ( 22754487 )
2012
23
Ghrelin in gastrointestinal disease. ( 21458525 )
2011
24
Changing prevalence of some selected gastrointestinal diseases vis-A -vis H. pylori infection. ( 21830443 )
2011
25
Helicobacter pylori infection and gastritis: the Systematic Investigation of gastrointestinaL diseases in China (SILC). ( 21198827 )
2011
26
The management of gastrointestinal disease in Hermansky-Pudlak syndrome. ( 21085008 )
2011
27
Cystic fibrosis gene mutations and gastrointestinal diseases. ( 20442009 )
2010
28
Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease. ( 20399894 )
2010
29
Campylobacteriosis and other bacterial gastrointestinal diseases in Sofia, Bulgaria for the period 1987-2008. ( 20122383 )
2010
30
Epidemiology of peptic ulcer disease: endoscopic results of the systematic investigation of gastrointestinal disease in China. ( 20736940 )
2010
31
[Relationship between gene polymorphisms in MMP-9 and Helicobacter pylori-related upper gastrointestinal disease in children]. ( 20416216 )
2010
32
Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome. ( 21154171 )
2010
33
NOD2/CARD15 genotype and common gastrointestinal diseases in 43,600 individuals. ( 19570052 )
2010
34
Collagenous gastritis: histopathologic features and association with other gastrointestinal diseases. ( 19295410 )
2009
35
Lactoferrin in gastrointestinal disease. ( 19652425 )
2009
36
Biomarkers for nononcologic gastrointestinal diseases. ( 19141347 )
2009
37
The role of the high-affinity IgE receptor, FcepsilonRI, in eosinophilic gastrointestinal diseases. ( 19141351 )
2009
38
[Significance of serum autotaxin activity in gastrointestinal disease]. ( 19522250 )
2009
39
Intestinal alkaline phosphatase: the molecular link between rosacea and gastrointestinal disease? ( 19573995 )
2009
40
Chemotactic factors associated with eosinophilic gastrointestinal diseases. ( 19141349 )
2009
41
Prevalence of clonorchiasis in patients with gastrointestinal disease: a Korean nationwide multicenter survey. ( 19115472 )
2009
42
Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease. ( 20029653 )
2009
43
Ghrelin in gastrointestinal diseases and disorders: a possible role in the pathophysiology and clinical implications (review). ( 19885611 )
2009
44
Application of ghrelin to gastrointestinal diseases. ( 18821473 )
2008
45
Dissecting the nutrigenomics, diabetes, and gastrointestinal disease interface: from risk assessment to health intervention. ( 18710364 )
2008
46
Comparison of V. parahaemolyticus isolated from seafoods and cases of gastrointestinal disease in the UK. ( 18668416 )
2008
47
The SEEDs of two gastrointestinal diseases: socioeconomic, environmental, and demographic factors related to cryptosporidiosis and giardiasis in Massachusetts. ( 18706542 )
2008
48
[Mechanism of action of Nizhne-Ivkinskaya 2K sulfate-calcium mineral water in combined treatment of acid-dependent gastrointestinal diseases]. ( 18326222 )
2008
49
Patterns of gastrointestinal disease associated with mutations of CFTR. ( 18625144 )
2008
50
Irritable bowel syndrome: a single gastrointestinal disease or a general somatoform disorder? ( 18501255 )
2008

Variations for Gastrointestinal System Disease

Expression for Gastrointestinal System Disease

Search GEO for disease gene expression data for Gastrointestinal System Disease.

Pathways for Gastrointestinal System Disease

Pathways related to Gastrointestinal System Disease according to GeneCards Suite gene sharing:

(show all 11)
# Super pathways Score Top Affiliating Genes
1
Show member pathways